ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,276, issued on Sept. 29, was assigned to 3H BIO. Co. LTD. (Gyeonggi-do, South Korea).
"Peptide used for immunotherapeutics" was invented by Hyo Joon Kim (Gyeonggi-Do, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a peptide provided herein includes at least one peptide unit, and the peptide unit may include at least one B-cell epitope, at least one Th epitope, and an appropriate number of auxiliary parts. The peptide unit is a portion designed to uniformly induce only the intended antibody while exhibiting a certain level of immunogenicity in the body of a subject. In addition, the peptide unit is designed with a relatively ...